What is the appropriate diagnosis and treatment plan for a 32-year-old male with recurrent major depressive disorder, generalized anxiety disorder, multiple prior suicide attempts, a recent acute suicidal crisis precipitated by a panic reaction to quetiapine (Seroquel) and trazodone, ongoing daily cannabis (THC) and kratom use, tobacco dependence, flat affect, poor insight, and minimal cooperation?

Diagnosis and Treatment Plan

This patient requires continued inpatient psychiatric hospitalization with immediate discontinuation of quetiapine and trazodone, initiation of lithium or consideration of ketamine infusion for acute suicidal ideation, structured cognitive behavioral therapy focused on suicide prevention, and mandatory substance use disorder treatment addressing daily cannabis and kratom use.

Primary Diagnoses

Major Depressive Disorder, Recurrent, Severe with active suicidal ideation despite patient minimization. The 16-year depression history, recent high-lethality suicide attempt (wrist cutting with intent to bleed to death), rapid decompensation post-discharge, and current flat affect with poor insight confirm severe recurrent MDD 1.

Cannabis Use Disorder and Kratom Use Disorder - Daily THC and kratom use significantly complicate treatment and increase suicide risk. Substance use disorders are present in the majority of completed suicides and must be addressed concurrently 2.

Possible Borderline Personality Disorder - The pattern of impulsive suicide attempts, affective instability, difficulty with distress tolerance (attempting to jump from moving car), and chronic suicidality suggest BPD features requiring specific therapeutic approaches 1.

Critical Safety Assessment

The patient meets ALL high-risk criteria for continued inpatient hospitalization 3:

• Continues to endorse desire to die (per collateral information)
• Severely hopeless with poor insight
• Cannot engage in meaningful safety planning (minimizing symptoms, demanding discharge)
• Recent high-lethality attempt with clear expectation of death
• Rapid relapse within days of prior psychiatric discharge
• Active daily substance use
• Inadequate outpatient monitoring capacity

Immediate Medication Management

Discontinue Current Regimen

Stop quetiapine (Seroquel) and trazodone immediately. The patient experienced what he described as a "panic attack" with palpitations, nervousness, and severe discomfort after taking these medications, which he directly links to triggering suicidal thoughts. The FDA label for quetiapine specifically warns that antidepressants (quetiapine is used for depression) can cause anxiety, agitation, panic attacks, akathisia (psychomotor restlessness), and emergence of suicidality, particularly in patients aged 18-24 4. His age (32) and presentation (restlessness, anxiety during interview) suggest possible akathisia or activation syndrome from these medications.

Initiate Evidence-Based Pharmacotherapy

First-line recommendation: Lithium maintenance therapy. Lithium has the strongest evidence for reducing suicide risk in patients with unipolar depression, with multiple cohort studies and systematic reviews demonstrating reduced suicidal behaviors and deaths 1. This is particularly appropriate given his recurrent depression and multiple prior attempts 2.

Alternative for acute crisis: Ketamine infusion (0.5 mg/kg IV over 40 minutes). If suicidal ideation remains severe despite hospitalization, ketamine produces rapid improvement in suicidal ideation within 24 hours, with 55-60% of patients reporting no suicidal ideation at 24 hours to 7 days 1, 5, 1. However, this is a short-term bridge requiring concurrent long-term treatment 6.

Avoid benzodiazepines given his daily cannabis and kratom use - this represents active polysubstance use disorder. Use of an atypical antipsychotic other than quetiapine (such as low-dose aripiprazole) may be considered for acute anxiety/agitation instead of benzodiazepines 7.

Structured Psychotherapy - Non-Negotiable

Cognitive Behavioral Therapy (CBT) focused on suicide prevention is mandatory. CBT reduces suicide attempts by 50% compared to treatment as usual in patients who attempted suicide within the past 6 months 1. Most patients require fewer than 12 sessions to show benefit 1.

Dialectical Behavior Therapy (DBT) if borderline personality disorder is confirmed. DBT specifically reduces suicidal and non-suicidal self-directed violence in patients with BPD and recent suicide attempts 1. DBT combines CBT with skills training in emotion regulation, interpersonal effectiveness, and distress tolerance - all deficient in this patient 1.

Crisis Response Planning must be developed collaboratively before any discharge consideration 1. This includes:

• Identifying behavioral/cognitive/affective warning signs of crisis
• Self-management distraction techniques
• Social supports he can contact (family/friends he mentioned)
• Professional crisis resources and suicide lifeline
• Specific follow-up appointments scheduled before discharge

Substance Use Disorder Treatment

Concurrent treatment for cannabis and kratom use disorder is essential - these substances worsen depression, impair judgment, and increase impulsivity 2, 8. The patient's daily use represents severe use disorder requiring:

• Motivational interviewing (MI) to address ambivalence about stopping
• CBT targeting both depression and substance use simultaneously 9
• Structured outpatient substance use treatment upon discharge

Note: Quetiapine has been studied for cannabis use disorder with modest benefit in reducing heavy to moderate use 10, but given this patient's adverse reaction to quetiapine, this is not an option.

Means Restriction Counseling

Before any discharge, conduct detailed means restriction counseling with patient and mother 3:

• Remove ALL medications from home (given his stated plan to overdose)
• Secure or remove knives (given prior wrist cutting)
• Assess for firearms in home or homes of relatives/friends
• 24% of near-lethal suicide attempts occur within 0-5 minutes of decision, making impulsive access to means critical 3

Discharge Planning - Only When Stabilized

Discharge criteria must include 3:

• No active suicidal ideation for sustained period
• Ability to engage in safety planning discussion
• Commitment to outpatient treatment and substance use treatment
• Family able to provide adequate monitoring
• Scheduled appointments within 48-72 hours of discharge
• Demonstrated medication adherence during hospitalization

Post-discharge interventions:

• Periodic caring communications (postal mail, text messages) for 12 months following hospitalization reduce suicide attempts 6
• Intensive outpatient program or partial hospitalization rather than standard outpatient care given rapid prior relapse 3

Common Pitfalls to Avoid

1. Do not rely on patient's self-report alone - he is minimizing symptoms and demanding discharge. Collateral information from ED and mother reveals much higher risk 3.

2. Do not continue medications that may be causing activation/akathisia - the temporal relationship between quetiapine/trazodone and his panic-like symptoms with subsequent suicidal crisis is concerning 4.

3. Do not discharge based on denial of suicidal ideation - his poor insight, flat affect, and minimization despite recent high-lethality attempt indicate ongoing high risk 3.

4. Do not treat depression without addressing substance use - 78% of suicide attempts are attributable to time spent depressed, but active substance use dramatically worsens outcomes 2, 11, 8.

5. Do not use "no-suicide contracts" - these are ineffective. Use structured safety planning instead 3.